CUSIP 69353Y103COMPMVPQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
62 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bml Capital Management, LLC | 5.29M | $6.62M | 0 | Held |
| 2 | Orbimed Advisors LLC | 4.98M | $6.22M | −1.00M | Reduced |
| 3 | Tang Capital Management LLC | 4.94M | $6.17M | +154.8K | Added |
| 4 | Arrowmark Colorado Holdings LLC | 3.09M | $3.86M |
| −211.2K |
| Reduced |
| 5 | Sio Capital Management, LLC | 2.64M | $3.30M | 0 | Held |
| 6 | Euclidean Capital LLC | 2.63M | $3.28M | 0 | Held |
| 7 | Vanguard Group Inc | 2.17M | $2.71M | +7.3K | Added |
| 8 | Stonepine Capital Management, LLC | 1.15M | $1.44M | −219.4K | Reduced |
| 9 | Blackrock, Inc. | 1.09M | $1.37M | −9.3K | Reduced |
| 10 | Two Sigma Advisers, LP | 874.1K | $1.09M | +456.2K | Added |
See every fund holding Pmv Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders